(Q39169203)

9 September 2017

miR-708 promotes the development of bladder carcinoma via direct repression of Caspase-2. (English)

1 reference

9 September 2017

1 reference

Tao Song

1

1 reference

9 September 2017

Xu Zhang

2

1 reference

9 September 2017

Lei Zhang

3

1 reference

9 September 2017

Jun Dong

4

1 reference

9 September 2017

Wei Cai

5

1 reference

9 September 2017

Jiangping Gao

6

1 reference

9 September 2017

Baofa Hong

7

1 reference

9 September 2017

9 April 2013

1 reference

Journal of Cancer Research and Clinical Oncology

9 September 2017

1 reference

9 September 2017

139

1 reference

9 September 2017

7

1 reference

9 September 2017

1189-1198

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-013-1392-6

9 September 2017

0 references

cites work

Bladder cancer biomarkers: current developments and future implementation

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

Time-course gait analysis of hemiparkinsonian rats following 6-hydroxydopamine lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

The treated natural history of high risk superficial bladder cancer: 15-year outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

MicroRNAs as regulators of signal transduction in urological tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

21 January 2018

MicroRNAs as oncogenes

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

Caspase-2 is an initiator caspase responsible for pore-forming toxin-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

Chemotherapy in advanced bladder cancer: current status and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

5-Phenylselenyl- and 5-methylselenyl-methyl-2'-deoxyuridine induce oxidative stress, DNA damage, and caspase-2-dependent apoptosis in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

Caspase-2: controversial killer or checkpoint controller?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

Caspases in cell survival, proliferation and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

Therapeutic microRNA strategies in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

The roles of microRNA in cancer and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

TAp73alpha protects small cell lung carcinoma cells from caspase-2 induced mitochondrial mediated apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

MicroRNAs: regulators of oncogenesis and stemness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

Tumor-suppressing function of caspase-2 requires catalytic site Cys-320 and site Ser-139 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

miRNA-708 control of CD44(+) prostate cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

A meta-analysis of randomised trials suggests a survival benefit for combined radiotherapy and radical cystectomy compared with radical radiotherapy for invasive bladder cancer: are these data relevant to modern practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

MicroRNA function in cancer: oncogene or a tumor suppressor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

In vitro efficacy of Fas ligand gene therapy for the treatment of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

Structural and Enzymatic Insights into Caspase-2 Protein Substrate Recognition and Catalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

21 January 2018

Caspases: enemies within

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

Loss of caspase-2-dependent apoptosis induces autophagy after mitochondrial oxidative stress in primary cultures of young adult cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

MicroRNAs as potential cancer therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

MicroRNA-based therapeutics for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

Norsolorinic acid inhibits proliferation of T24 human bladder cancer cells by arresting the cell cycle at the G0/G1 phase and inducing a Fas/membrane-bound Fas ligand-mediated apoptotic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

Apoptosis in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

microRNAs as oncogenes and tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1392-6

Characterization of microRNAs expression profiling in one group of Chinese urothelial cell carcinoma identified by Solexa sequencing

21 January 2018

1 reference

12 December 2020

MicroRNAs: small but potent oncogenes or tumor suppressors.

1 reference

12 December 2020

Differential miRNA expression profiles in bladder urothelial carcinomas

1 reference

12 December 2020

A novel immunotherapy for superficial bladder cancer by the immobilization of streptavidin-tagged bioactive IL-2 on the biotinylated mucosal surface of the bladder wall.

1 reference

12 December 2020

10.1007/S00432-013-1392-6

Identifiers

DOI

1 reference

9 September 2017

1 reference